DIFESA CAPITAL MANAGEMENT, LP - EUROPEAN BIOTECH ACQUTN CORP ownership

Back to all holdings Add to watchlist

EUROPEAN BIOTECH ACQUTN CORP's ticker is EBACW and the CUSIP is G3167F128. A total of 35 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
DIFESA CAPITAL MANAGEMENT, LP ownership history of EUROPEAN BIOTECH ACQUTN CORP
ValueSharesWeighting
Q3 2022$1,000
-50.0%
14,1590.0%0.00%0.0%
Q2 2022$2,000
-33.3%
14,1590.0%0.00%
-50.0%
Q1 2022$3,000
-62.5%
14,1590.0%0.00%
-60.0%
Q4 2021$8,000–14,159–0.01%–
 Download
Other shareholders
EUROPEAN BIOTECH ACQUTN CORP shareholders Q4 2022
NameSharesValueWeighting ↓
Tyrus Capital S.A.M. 133,332$39,7330.09%
ANGELO GORDON & CO., L.P. 13,333$134,6630.02%
Radcliffe Capital Management, L.P. 66,566$672,3170.02%
Dryden Capital, LLC 15,000$4,4700.01%
METEORA CAPITAL, LLC 50,000$14,9000.00%
Arena Capital Advisors, LLC- CA 19,251$5,7370.00%
MMCAP International Inc. SPC 73,525$21,9100.00%
PERISCOPE CAPITAL INC. 196,896$57,5710.00%
MARSHALL WACE, LLP 36,056$364,1650.00%
CLEAR STREET LLC 217,000$650.00%
View complete list of EUROPEAN BIOTECH ACQUTN CORP shareholders